Tag: Belimumab

Systemic lupus erythematosus (SLE) affects an estimated 204,295 people in the United States. When considering treatment, a key question is: **Is Saphnelo stronger than Benlysta?** While they are generally comparable, their strengths differ based on the patient's specific lupus symptoms and profile.

Benlysta (belimumab) was the first self-injectable biologic medication approved for the treatment of systemic lupus erythematosus (SLE) in over 50 years. This innovative option allows many patients to self-administer their weekly dose from the comfort of their home, offering a new level of convenience for those seeking to manage their lupus symptoms. The once a week injection for lupus is a targeted therapy that works differently than broad immunosuppressants or steroids.